These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4380943)

  • 1. Antifibrillatory properties of hydrazine derivatives in experimental acute coronary insufficiency.
    Popova NK
    Fed Proc Transl Suppl; 1966; 25(6):997-9. PubMed ID: 4380943
    [No Abstract]   [Full Text] [Related]  

  • 2. [The antifibrillary properties of hydrazine derivatives in experimental acute coronary insufficiency].
    Popova NK
    Farmakol Toksikol; 1966; 29(1):44-7. PubMed ID: 5988615
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in the arterial bed of the myocardium following administration of hydrazine derivatives].
    Shmerling MD; Popova NK; Kislaia TV
    Arkh Anat Gistol Embriol; 1966 Jun; 50(6):58-64. PubMed ID: 4386073
    [No Abstract]   [Full Text] [Related]  

  • 4. [ANTI-FIBRILLATION PROPERTIES OF SOME HYDRAZINE DERIVATIVES].
    POPOVA NK; ILIUCHENOK RIu; SERGIEVSKII VS
    Farmakol Toksikol; 1964; 27():454-7. PubMed ID: 14188541
    [No Abstract]   [Full Text] [Related]  

  • 5. [The antifibrillatory properties of bonnecor].
    Grigor'eva EK; Gorbunova VV
    Farmakol Toksikol; 1990; 53(3):36-7. PubMed ID: 2387377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiarrhythmic properties of fubromegan on different models of experimental cardiac arrhythmia].
    Samvelian VM; L'vov MV
    Farmakol Toksikol; 1970; 33(3):309-13. PubMed ID: 4393833
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacologic prevention of fibrillation in acute ischemia of the heart and the dynamics of electrolytes].
    Popova NK; Ivashkevich EI
    Biull Eksp Biol Med; 1965 May; 59(5):64-7. PubMed ID: 5880812
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antifibrillatory properties of new alkoxynaphthoic acid-esters in comparison with quinidine and procaine amide].
    Igarashi T; Hashimoto N
    Arzneimittelforschung; 1968 Oct; 18(10):1274-8. PubMed ID: 5755706
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of cardiac vulnerability and antifibrillatory properties of anti-arrhythmic drugs.
    Smailys A; Gasiunas V; Gasiuniene G
    Resuscitation; 1989 Oct; 18(1):21-30. PubMed ID: 2554443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transthoracic defibrillation of cardiac ventricles: effects of novocainamide on effectiveness of an electric impulse of bipolar sinusoidal shape].
    Vostrikov VA; Bogushevich MS; Mikhaĭlov IV
    Patol Fiziol Eksp Ter; 1999; (2):23-6. PubMed ID: 10379179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of lignocaine, quinidine, propranolol and procainamide as antifibrillatory agents.
    Murnaghan MF
    Br J Pharmacol; 1970 Sep; 40(1):149P. PubMed ID: 5487011
    [No Abstract]   [Full Text] [Related]  

  • 12. The prophylactic use of anti-arrhythmic drugs in acute myocardial infarction.
    Chung EK
    Singapore Med J; 1973 Sep; 14(3):205-10. PubMed ID: 4591400
    [No Abstract]   [Full Text] [Related]  

  • 13. Drugs in cardiopulmonary resuscitation.
    Kirimli B; Harris LC; Safar P
    Acta Anaesthesiol Scand Suppl; 1966; 23():255-9. PubMed ID: 4953000
    [No Abstract]   [Full Text] [Related]  

  • 14. Procainamide: Test your drug IQ.
    Gever MP
    Nursing; 2006; 36(5 Suppl E D):25. PubMed ID: 16641699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of antifibrillatory compounds in the series of local anesthetics].
    Faucon G; Arnaud P; Kofman J; Frederich A; Lavarenne J
    Therapie; 1966; 21(5):1253-65. PubMed ID: 5981329
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardioprotective, inotropic, and anti-arrhythmia properties of a complex adaptogen "Tonizid"].
    Lishmanov IuB; Maslov LN; Arbuzov AG; Krylatov AV; Platonov AA; Burkova VN; Kaiumova EA
    Eksp Klin Farmakol; 2008; 71(3):15-22. PubMed ID: 18652250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments].
    Timour Q; Freysz M; Aupetit JF; Loufoua J; Frassati D; Faucon G
    Bull Acad Natl Med; 1996 Jan; 180(1):215-26; discussion 226-7. PubMed ID: 8696877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of lithium hydroxybutyrate and lithium chloride on heart rhythm disorders of various origins].
    Galenko-Iaroshevskiĭ PA; Shadurskiĭ KS; Tikhonov AV
    Farmakol Toksikol; 1984; 47(4):54-9. PubMed ID: 6090202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer properties of isoniazid & hydrazine-sulphate.
    Bhide SV
    Indian J Exp Biol; 1978 Aug; 16(8):926-8. PubMed ID: 711258
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-arrhythmic properties of specific bradycardic agents from the group of 2-mercaptobenzimidazole derivatives].
    Chichkanov GG; Tsorin IB; Kirsanova GIu; Berdiaev SIu; Turilova AI
    Eksp Klin Farmakol; 1997; 60(5):35-9. PubMed ID: 9483403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.